Fig. 2From: A transdermal treatment with MC903 ameliorates diet-induced obesity by reducing visceral fat and increasing myofiber thickness and energy consumption in miceThe transdermal MC903 treatment improved glucose metabolism without affecting serum VitD3 and calcium levels. A-D Blood glucose levels and their areas under the curve (AUC) in GTT and ITT. E Fasted serum insulin levels. F, G Serum 25-hydroxy-vitamin D3 and calcium levels at dissection. Data are presented as the mean ± SEM. N = 12–16 (A, B) or 5–8 (C-G). *p < 0.05, **p < 0.01 significantly different from Chow mice; †p < 0.05, ††p <  0.01 significantly different from HFD miceBack to article page